Irish Life Investment Managers’s Meridian Bioscience Inc VIVO Stock Holding History

Irish Life Investment Managers’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$31.6K	Buy	+1,473	New	+$31.8K	﹤0.01%	1707

Other funds holding VIVO

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

CPCM

Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

DRZID

DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.29B AUM 20.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Irish Life Investment Managers's VIVO Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in Meridian Bioscience Inc (VIVO) in Q2 2013: 1,473 shares worth $31.6K. The stake represents ﹤0.01% of the portfolio and ranks #1707 among its holdings.

163 funds tracked by Wall St. Rank hold VIVO as of Q2 2013.

Irish Life Investment Managers held 1,473 shares of Meridian Bioscience Inc worth $31.6K as of Q2 2013.
Meridian Bioscience Inc was a new Irish Life Investment Managers position in Q2 2013.
Meridian Bioscience Inc made up ﹤0.01% of Irish Life Investment Managers's portfolio in Q2 2013, its #1707 holding.
163 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.